1 – 15 of 15
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Reply by Authors
(
- Contribution to journal › Article
-
Mark
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate
(
- Contribution to journal › Article
- 2019
-
Mark
A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy : An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
(
- Contribution to journal › Article
- 2016
-
Mark
The Molecular Evolution of Castration-resistant Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
The Potential of MicroRNAs as Prostate Cancer Biomarkers.
(
- Contribution to journal › Scientific review
-
Mark
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
The Mutational Landscape of Prostate Cancer
(
- Contribution to journal › Scientific review
- 2011
-
Mark
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.
(
- Contribution to journal › Article
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
(
- Contribution to journal › Article
-
Mark
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
(
- Contribution to journal › Letter
- 2002
-
Mark
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer
(
- Contribution to journal › Article
- 1995
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
(
- Contribution to journal › Article